메뉴 건너뛰기




Volumn 127, Issue 2, 2005, Pages 514-515

Catalytic enantioselective conjugate addition of cyanide to α,β-unsaturated N-acylpyrroles

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 3 PHENYLBUTYRIC ACID; 4 AMINOBUTYRIC ACID; BETA AMINO ACID; CARBOXYLIC ACID DERIVATIVE; CINNAMIC ACID DERIVATIVE; CYANIDE; CYCLOPENTANEDICARBOXYLIC ACID; GADOLINIUM; PREGABALIN; PYRROLE DERIVATIVE; UNCLASSIFIED DRUG;

EID: 12944296640     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja043424s     Document Type: Article
Times cited : (150)

References (16)
  • 9
    • 12944269222 scopus 로고    scopus 로고
    • note
    • Catalysts prepared from other lanthanide alkoxides produced less satisfactory results.
  • 10
    • 12944251193 scopus 로고    scopus 로고
    • note
    • 3 (0.2 M in THF, 75 μL, 0.015 mmol) was added to a solution of 2 (13.8 mg, 0.030 mmol) in THF (0.3 mL) at 0°C. The mixture was stirred at 45°C for 1 h, and then the solvent was evaporated at ambient temperature. After drying the resulting precatalyst under reduced pressure (<5 mmHg) for 1.5 h. substrate 7f (53.1 mg. 0.30 mmol) in propionitrile (500 μL) was added at room temperature, then cooled to -20°C. After 20 min, TMSCN (20 μL, 0.15 mmol) was added, and after 10 min, HCN (4 M in propionitrile stock solution, 150 μL, 0.60 mmol) was added to start the reaction.
  • 11
    • 12944332239 scopus 로고    scopus 로고
    • note
    • The cyanide addition proceeded with high enantioselectivity. Lack of the diastereoselectivity is due to the nonstereoselective protonation of the intermediate enolate.
  • 14
    • 12944262565 scopus 로고    scopus 로고
    • U.S. Patent 5,563,175, 1996
    • Pregabalin has a (3S) configuration: (a) Silverman, R. B.; Andruszkiewicz, R.; Yuen, P.-W.; Sobieray, D. M.; Franklin, L. C.; Schwindt, M. A. U.S. Patent 5,563,175, 1996. For recent catalytic enantioselective synthesis of pregabalin, see: (b) Hoge, G. J. Am. Chem. Soc. 2003, 125, 10219, and ref 1a. For a practical synthesis of (ent)-ligand 2, see: (c) Kato, N.; Tomita, D.; Maki, K.; Kanai, M.; Shibasaki, M. J. Org. Chem. 2004, 69, 6128.
    • Silverman, R.B.1    Andruszkiewicz, R.2    Yuen, P.-W.3    Sobieray, D.M.4    Franklin, L.C.5    Schwindt, M.A.6
  • 15
    • 0042932780 scopus 로고    scopus 로고
    • and ref 1a
    • Pregabalin has a (3S) configuration: (a) Silverman, R. B.; Andruszkiewicz, R.; Yuen, P.-W.; Sobieray, D. M.; Franklin, L. C.; Schwindt, M. A. U.S. Patent 5,563,175, 1996. For recent catalytic enantioselective synthesis of pregabalin, see: (b) Hoge, G. J. Am. Chem. Soc. 2003, 125, 10219, and ref 1a. For a practical synthesis of (ent)-ligand 2, see: (c) Kato, N.; Tomita, D.; Maki, K.; Kanai, M.; Shibasaki, M. J. Org. Chem. 2004, 69, 6128.
    • (2003) J. Am. Chem. Soc. , vol.125 , pp. 10219
    • Hoge, G.1
  • 16
    • 4344651527 scopus 로고    scopus 로고
    • Pregabalin has a (3S) configuration: (a) Silverman, R. B.; Andruszkiewicz, R.; Yuen, P.-W.; Sobieray, D. M.; Franklin, L. C.; Schwindt, M. A. U.S. Patent 5,563,175, 1996. For recent catalytic enantioselective synthesis of pregabalin, see: (b) Hoge, G. J. Am. Chem. Soc. 2003, 125, 10219, and ref 1a. For a practical synthesis of (ent)-ligand 2, see: (c) Kato, N.; Tomita, D.; Maki, K.; Kanai, M.; Shibasaki, M. J. Org. Chem. 2004, 69, 6128.
    • (2004) J. Org. Chem. , vol.69 , pp. 6128
    • Kato, N.1    Tomita, D.2    Maki, K.3    Kanai, M.4    Shibasaki, M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.